Platelet dysfunction as the cause of spontaneous bleeding in two haemophilic patients taking HIV protease inhibitors
Pollmann, H.; Richter, H.; Jürgens, H.
Thrombosis and Haemostasis 79(6): 1213-1214
1998
ISSN/ISBN: 0340-6245 PMID: 9657450 Document Number: 495943
Document emailed within 1 workday
Related Documents
Collen, D.; Lu, H.R.; Stassen, J.M.; Vreys, I.; Yasuda, T.; Bunting, S.; Gold, H.K. 1994: Antithrombotic effects and bleeding time prolongation with synthetic platelet GPIIb/IIIa inhibitors in animal models of platelet-mediated thrombosis Thrombosis and Haemostasis 71(1): 95-102Hermanides, R.S.; Ottervanger, J.P.; ten Berg, J.M.; Gosselink, A.T.M.; van Houwelingen, G.; Dambrink, J.-H.E.; Stella, P.R.; Hamm, C.; van 't Hof, A.W.J. 2012: Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score Journal of Invasive Cardiology 24(3): 84-89
Berthier, A.; Chamaret, S.; Fauchet, R.; Fonlupt, J.; Genetet, N.; Gueguen, M.; Pommereuil, M.; Ruffault, A.; Montagnier, L. 1986: Transmissibility of human immunodeficiency virus in haemophilic and non-haemophilic children living in a private school in France Lancet 2(8507): 598-601
Choi, J.-y.; Kwon, O.-K.; Choi, S.Y.; Park, Y.K.; Kim, S.S. 2011: Drug susceptibility of human immunodeficiency virus type 1-derived pseudoviruses from treatment-experienced patients to protease inhibitors and reverse transcriptase inhibitors, using a modified single-round assay Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 50(1): 19-25
Lindemann, S.; Klingel, B.; Fisch, A.; Meyer, J.; Darius, H. 1999: Increased platelet sensitivity toward platelet inhibitors during physical exercise in patients with coronary artery disease Thrombosis Research 93(2): 51-59
Cattaneo, M.; Pareti, F.I.; Zighetti, M.; Lecchi, A.; Lombardi, R.; Mannucci, P.M. 1995: Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP: correlation with the bleeding time Journal of Laboratory and Clinical Medicine 125(4): 540-547
Rao, A.K.; Ghosh, S.; Sun, L.; Yang, X.; Disa, J.; Pickens, P.; Polansky, M. 1995: Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects. a double-blind placebo-controlled trial Thrombosis and Haemostasis 74(4): 1071-1078
Mullakandov, S.A.; Gafarov, E.K.; Nabiev, U.A. 1985: Use of protease inhibitors on burn patients Klinicheskaia Khirurgiia 3: 43-44
Sommadossi; Murphy 1997: Protease Inhibitors Therapy for AIDS Patients Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 1(5): 226-229
Piatkowska, M.; Kotschy, M.; Rość, D.; Wiśniewska, E.; Opoka, J. 1994: Plasma serine protease inhibitors in patients with liver cirrhosis Acta Haematologica Polonica 25(2): 145-149
Chronister, C.L.; Gurwood, A.S. 1998: Type 2 diabetes in association with HIV-1 protease inhibitors in HIV-infected patients Journal of the American Optometric Association 69(11): 695-698
Barthélémy, O.; Escaut, L.; Vayre, F.; Gallet, B.; Pulik, M.; Heloire, F.; Vittecoq, D. 2002: Acute coronary syndromes in patients treated with HIV protease inhibitors Presse Medicale 31(8): 343-348
Swiatkowski, M.; Pulkowski, G.; Kłopocka, M.; Budzyński, J.; Wiśniewsk, E.; Kotschy, M. 2001: Serine protease inhibitors in plasma of patients with ulcerative colitis Przeglad Lekarski 58(2): 67-70
Kłoczko, J.; Bielawiec, M.; Galar, M.; Czaczkowska, T.; Wojtukiewicz, M. 1991: Protein C and plasma serine protease inhibitors in patients with essential hypertension Polski Tygodnik Lekarski 46(50-52): 974-976
Gurgo, A.M.; Massino Ferri, F.; Iulianella, R.; Luciani, C.; Lucifero, A.; Staropoli, P.; Rocchi, M. 2001: Acute myocardial infarct in HIV-positive patients in treatment with protease inhibitors Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 2(11): 1236-1239
2003: Are all boosted protease inhibitors the same? Previously treated patients profit too from lopinavir/r MMW Fortschritte der Medizin 145(50): 61
Sumathi, S.; Pattabiraman, T.N. 1976: Natural plant enzyme inhibitors: Part II-protease inhibitors of seeds Indian Journal of Biochemistry and Biophysics 13(1): 52-56
Bhat, P.G.; Karnik, S.S.; Pattabiraman, T.N. 1976: Natural plant enzyme inhibitors: Part III-purification of protease inhibitors from Lathyrus sativus seeds Indian Journal of Biochemistry and Biophysics 13(4): 339-343
Rao, N.M.; Pattabiraman, T.N. 1985: Natural plant enzyme inhibitors: comparison of the action of tuber protease inhibitors on animal pancreatic systems Indian Journal of Biochemistry and Biophysics 22(6): 373-375
Le Moing, V.; Bissuel, F.; Costagliola, D.; Eid, Z.; Chapuis, F.; Molina, J.M.; Salmon-Ceron, D.; Brasseur, P.; Leport, C. 1998: Decreased prevalence of intestinal cryptosporidiosis in HIV-infected patients concomitant to the widespread use of protease inhibitors Aids 12(11): 1395-1397